Dr. Longo’s Pioneering Approach May Soon Lead to New Disease Modifying Drugs
The Foundation for Mitochondrial Medicine (FMM) is hosting its Hope Flies Health Series Webinar: Research Connecting Alzheimer’s and Mitochondrial Disease on Wednesday, September 23, 2015 at 12:00 pm EST. The Foundation developed the webinar with partners including the Alzheimer’s Drug Discovery Foundation (ADDF), MitoAction and Sharecare to particularly bring greater awareness to mitochondrial disease in conjunction with Global Mitochondrial Disease Awareness Week, beginning September 21.
Collaboration Advances Development of Therapeutics for the Treatment of Alzheimer’s Disease
The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year.
Melvin R. Goodes Prize Supports Innovative Projects by Top Researchers While Honoring Pioneering Legacy of Former Warner-Lambert CEO
Carmel Valley's newest winery, Jarman Wines, will introduce two premium varietals to benefit the Alzheimer's Drug Discovery Foundation (ADDF) and to honor the matriarch of the family whose name graces the wines created for her.
Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new, multicenter Alzheimer’s disease (AD) treatment trial, Rasagiline Rescue (R2), which is designed to determine if treatment with rasagiline is associated with improved brain glucose metabolism and improvement in memory.
A mother's voice is the first thing we hear from the time we exit the womb. And its the voice we continue to hear throughout our lives. We model our mother's voice when we first learn to talk. The same voice guides us as we begin to walk. It warns you of potential harm and radiates warmth when you need consolation.
On Monday, April 27, 2015, American theatre director, choreographer, film director and performer Susan Stroman hosted the Alzheimer’s Drug Discovery Foundation’s (ADDF) Ninth Annual Connoisseur’s Dinner at Sotheby’s in New York City. Co-chaired by Leonard A. Lauder of the Estée Lauder cosmetics family, the black-tie event featured fine wine, food and art. More than $2.8 million was raised to support Alzheimer's drug discovery and development
On Wednesday, April 15, 2015, renowned journalist and NPR host Diane Rehm welcomed guests to the Alzheimer’s Drug Discovery Foundation’s (ADDF) Fifth Annual Great Ladies Luncheon & Fashion Show at The Ritz-Carlton in Washington, DC. Rehm, who has long used her public platform to raise awareness for Alzheimer’s disease, spoke eloquently about the need to increase support for drug discovery for Alzheimer’s. She also expressed hope for the future, noting that “there are hundreds of new, potentially disease-modifying drugs in the pipeline.”